Oct1 is required for mTOR-induced G1 cell cycle arrest via the control of p27(Kip1) expression

Mathieu Dalvai1, Karin Schubart, Arnaud Besson

  • 1Friedrich Miescher Institute for Biomedical Research, Maulbeerstrase, Basel, Switzerland. Mathieu.dalvai@ibcg.biotoul.fr

Insights

Oct1 is crucial for cellular stress response, mediating growth arrest by controlling p27Kip1 expression. Cells lacking Oct1 bypass cell cycle arrest, highlighting Oct1

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Genetics

Background:

  • Oct1 is a transcription factor induced by DNA damage.
  • Cellular stress response involves cell cycle regulation.
  • The mTOR pathway regulates cell proliferation and is sensitive to nutrient availability.

Purpose of the Study:

  • To investigate the role of Oct1 in the cellular stress response.
  • To determine Oct1's involvement in mTOR-mediated proliferation control.
  • To elucidate Oct1's function in nutrient starvation-induced cell cycle arrest.

Main Methods:

  • Utilized Oct1-deficient mouse embryonic fibroblasts.
  • Studied cell proliferation under glucose and amino acid starvation.
  • Assessed mTOR pathway activity and rapamycin sensitivity.
  • Analyzed the expression of CDK inhibitor p27Kip1.

Main Results:

  • Oct1-deficient cells proliferated continuously, bypassing G1 arrest during starvation.
  • mTOR-mediated proliferation control was abolished in Oct1-null cells.
  • Oct1-null cells were insensitive to mTOR inhibition by rapamycin or nutrient deprivation.
  • Oct1 controls p27Kip1 transcription downstream of mTOR; Oct1-null cells failed to upregulate p27Kip1.

Conclusions:

  • Oct1 is a critical mediator of growth arrest induced by mTOR inhibition.
  • Oct1 regulates p27Kip1 expression, essential for G1 arrest during nutrient stress.
  • Oct1 plays a key role in the cellular response to nutrient availability and stress.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.